Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Jim Ellis, MD, won The Winning Pitch Challenge at the 2021 ASCRS Annual Meeting in Las Vegas, Nevada, for the JelliSee accommodating IOL. Dr. Ellis spoke to EyeWorld about the progress made with the product since winning the competition.
At The Winning Pitch Challenge in 2020, the top prize went to Sunil Shah, MD, presenting on Photon Therapeutics and its device for ultraviolet light treatment for corneal infections. Simon Dean, MBChB, MSc, spoke with EyeWorld about the company’s technology and updates since winning the competition.
The use of autologous blood eye drops continues to be a point of interest in research and as a potential cost-effective alternative to processed hemoderivatives. A recent study published in the journal Clinical Ophthalmology continues to advance the topic.
Following updates to prescribing information on pilocarpine 1.25% and release of the ASCRS Consensus Statement on the topic, several members of the ASCRS leadership sat down to discuss presbyopia-correcting drops. Sumit “Sam” Garg, MD, EyeWorld Chief Medical Editor, led a discussion with Elizabeth Yeu, MD, Cathleen McCabe, MD, and Douglas Rhee, MD. They addressed some of the reported adverse events, how to examine and speak to patients about the product, uses of pilocarpine in the glaucoma field, and more.
Constance Okeke, MD, is a wife, mother, surgeon, researcher, assistant professor, consultant, and a soon-to-be two-time book author. EyeWorld caught up with her to learn more about her latest written endeavor and get some insights on what the process of book writing is like for a busy ophthalmologist.
EyeWorld Chief Medical Editor Sumit “Sam” Garg, MD, wrote about some of the ways that the society, the publication, and ophthalmology as a whole are changing.
In August, the Prescribing Information for VUITY (pilocarpine) was updated following a voluntary submission by Allergan to the FDA. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of Vuity.
With recent case reports showing rare but serious adverse effects with the use of Vuity (pilocarpine, Allergan), EyeWorld spoke with Dagny Zhu, MD, to gain additional insights and perspectives. She commented on the adverse effects, her recommendations for counseling and prescribing, and an off-label use she has found for the product.
Cataract Editor Rosa Brage-Mele, MD, previewed the articles in the section and introduced the new Cataract Editor, Mitchell Weikert, MD.
Refractive Editor Vance Thompson, MD, shared his thoughts on the “hot topics” covered in the section and introduced the new Refractive Editor, Karolinne Rocha, MD, PhD.
Get the latest ophthalmology news delivered to your inbox every Friday.